197 related articles for article (PubMed ID: 37310060)
1. Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors.
Wu Y; Zhao T; Cai Y; Zheng M; Zhang Y; Qu Y; Cai Q
J Neurosurg; 2024 Jan; 140(1):69-79. PubMed ID: 37310060
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors.
Kim BS; Kim Y; Kong DS; Nam DH; Lee JI; Suh YL; Seol HJ
J Neurosurg; 2018 Dec; 129(6):1384-1396. PubMed ID: 29372881
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes in central nervous system solitary-fibrous tumor/hemangiopericytoma: a STROBE-compliant single-center analysis.
Yu Y; Hu Y; Lv L; Chen C; Yin S; Jiang S; Zhou P
World J Surg Oncol; 2022 May; 20(1):149. PubMed ID: 35538540
[TBL] [Abstract][Full Text] [Related]
4. Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors.
Zeng L; Wang Y; Wang Y; Han L; Niu H; Zhang M; Ke C; Chen J; Lei T
J Neurooncol; 2017 Jan; 131(1):153-161. PubMed ID: 27671018
[TBL] [Abstract][Full Text] [Related]
5. A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.
Giordan E; Marton E; Wennberg AM; Guerriero A; Canova G
Neurosurg Rev; 2021 Jun; 44(3):1299-1312. PubMed ID: 32556679
[TBL] [Abstract][Full Text] [Related]
6. Solitary Fibrous Tumor of Central Nervous System: Clinical and Prognostic Study of 24 Cases.
Jiang N; Xie YY; Chen W; Peng ZF; Yuan XR; Li XJ; Feng CY; Wang-Gou SY
World Neurosurg; 2017 Mar; 99():584-592. PubMed ID: 28017751
[TBL] [Abstract][Full Text] [Related]
7. Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification.
Shin DW; Kim JH; Chong S; Song SW; Kim YH; Cho YH; Hong SH; Nam SJ
J Neurooncol; 2021 Sep; 154(2):171-178. PubMed ID: 34417710
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of spinal solitary fibrous tumor/hemangiopericytoma: a case series of 20 patients.
Jia Q; Zhou Z; Zhang D; Yang J; Liu C; Wang T; Wu Z; Yang C; Wei H; Zhao J; Liu T; Zhou W; Yang X; Xiao J
Eur Spine J; 2018 Apr; 27(4):891-901. PubMed ID: 29127512
[TBL] [Abstract][Full Text] [Related]
9. Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system.
Boyett D; Kinslow CJ; Bruce SS; Sonabend AM; Rae AI; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Wang TJC
J Neurooncol; 2019 Jul; 143(3):457-464. PubMed ID: 31054100
[TBL] [Abstract][Full Text] [Related]
10. Effect of Different Treatments for Intracranial Solitary Fibrous Tumors: Retrospective Analysis of 31 Patients.
Li Q; Deng W; Sun P
World Neurosurg; 2022 Oct; 166():e60-e69. PubMed ID: 35760325
[TBL] [Abstract][Full Text] [Related]
11. Solitary Fibrous Tumor/Hemangiopericytoma of Spinal Cord: A Retrospective Single-Center Study of 16 Cases.
Wang J; Zhao K; Han L; Jiao L; Liu W; Xu Y; Niu H; Ke C; Shu K; Lei T
World Neurosurg; 2019 Mar; 123():e629-e638. PubMed ID: 30554000
[TBL] [Abstract][Full Text] [Related]
12. [Solitary fibrous tumor/hemangiopericytoma of central nervous system: a clinicopathologic analysis of 71 cases].
Li XL; Fu WW; Zhang S; Chen DY; Chen YP; Wu J; Liu XY; Li GP; Lin SM; Luo S; Cai SS; Guo W; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):465-470. PubMed ID: 28728219
[No Abstract] [Full Text] [Related]
13. Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification.
Sung KS; Moon JH; Kim EH; Kang SG; Kim SH; Suh CO; Kim SH; Lee KS; Chang WS; Chang JH
J Neurosurg; 2018 Mar; 130(2):418-425. PubMed ID: 29521591
[TBL] [Abstract][Full Text] [Related]
14. A Single-Center Retrospective Analysis of Intracranial and Spinal Solitary Fibrous Tumor/Hemangiopericytoma Clinical Outcomes: Sex Association With Aggressiveness.
El-Abtah ME; Murayi R; Ejikeme T; Ahorukomeye P; Petitt JC; Soni P; Recinos PF; Kshettry VR
World Neurosurg; 2023 Jan; 169():e190-e196. PubMed ID: 36415015
[TBL] [Abstract][Full Text] [Related]
15. Intracranial solitary fibrous tumor/hemangiopericytomas: a clinical analysis of a series of 17 patients.
Chenhui Z; He G; Wu Z; Rong J; Ma F; Wang Z; Fang J; Gao W; Song H; Zhang F; Di G; Jiang X
Br J Neurosurg; 2024 Jun; 38(3):617-624. PubMed ID: 34334066
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of solitary fibrous tumor/hemangiopericytoma of central nervous system. Retrospective report of 17 patients and literature review.
Ma L; Wang L; Fang X; Zhao CH; Sun L
Neuro Endocrinol Lett; 2018 May; 39(2):88-94. PubMed ID: 30183202
[TBL] [Abstract][Full Text] [Related]
17. Meningeal solitary fibrous tumor/hemangiopericytoma: Emphasizing on STAT 6 immunohistochemistry with a review of literature.
Ahmad Z; Tariq MU; Din NU
Neurol India; 2018; 66(5):1419-1426. PubMed ID: 30233017
[TBL] [Abstract][Full Text] [Related]
18. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.
Kinslow CJ; Bruce SS; Rae AI; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sonabend AM; Wang TJC
J Neurooncol; 2018 May; 138(1):173-182. PubMed ID: 29427152
[TBL] [Abstract][Full Text] [Related]
19. Grading of meningeal solitary fibrous tumors/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132 patients.
Macagno N; Vogels R; Appay R; Colin C; Mokhtari K; ; ; Küsters B; Wesseling P; Figarella-Branger D; Flucke U; Bouvier C
Brain Pathol; 2019 Jan; 29(1):18-27. PubMed ID: 29600523
[TBL] [Abstract][Full Text] [Related]
20. The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11).
Lee JH; Jeon SH; Park CK; Park SH; Yoon HI; Chang JH; Suh CO; Kang SJ; Lim DH; Kim IA; Kim JH; Im JH; Kim SH; Wee CW; Kim IH
Cancer Res Treat; 2022 Jan; 54(1):65-74. PubMed ID: 33781051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
